Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Cancer Lett. 2011 Jan 1;300(1):10-9. doi: 10.1016/j.canlet.2010.09.019. Epub 2010 Oct 20.

MicroRNAs, cancer and cancer stem cells.

Author information

  • 1Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, United States; Honors Tutorial College, Ohio University, Athens, OH 45701, United States.

Abstract

MicroRNAs regulate self-renewal, differentiation, and division of cells via post-transcriptional gene silencing. Aberrant microRNA levels, specifically an overall downregulation, are present in many cancers, as compared to their normal tissue counterparts. Therefore, a potential therapeutic use of microRNAs is to correct these aberrant transcript levels involved in the signaling pathways of cancer. This review focuses on the current knowledge of microRNAs and their involvement with cancer cells and cancer stem cells. The methods currently being used to develop miRNA-based cancer therapeutics are examined, and the limitations halting further progress are also discussed.

Published by Elsevier Ireland Ltd.

PMID:
20965651
[PubMed - indexed for MEDLINE]
PMCID:
PMC2991536
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk